Humana Inc. (NYSE:HUM) Given Consensus Recommendation of “Hold” by Analysts

Humana Inc. (NYSE:HUM) has been assigned an average recommendation of “Hold” from the twenty-six ratings firms that are presently covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a sell recommendation, sixteen have given a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $249.9130.

Several equities research analysts have recently issued reports on the stock. Leerink Partners increased their price objective on shares of Humana from $185.00 to $255.00 and gave the stock a “market perform” rating in a research report on Thursday, April 30th. Piper Sandler reissued a “neutral” rating and issued a $254.00 price objective (up from $182.00) on shares of Humana in a research report on Wednesday, May 13th. Raymond James Financial reissued an “outperform” rating and issued a $260.00 price objective on shares of Humana in a research report on Friday, May 1st. Jefferies Financial Group increased their price objective on shares of Humana from $235.00 to $290.00 in a research report on Thursday, April 30th. Finally, Evercore increased their price objective on shares of Humana from $195.00 to $250.00 in a research report on Thursday, April 30th.

Insiders Place Their Bets

In other news, insider Sanjay K. Shetty purchased 810 shares of the stock in a transaction that occurred on Monday, February 23rd. The stock was acquired at an average cost of $185.21 per share, with a total value of $150,020.10. Following the acquisition, the insider owned 11,657 shares in the company, valued at approximately $2,158,992.97. This trade represents a 7.47% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.20% of the company’s stock.

Institutional Investors Weigh In On Humana

Large investors have recently added to or reduced their stakes in the company. Illinois Municipal Retirement Fund grew its holdings in Humana by 9.6% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 49,658 shares of the insurance provider’s stock valued at $12,920,000 after purchasing an additional 4,351 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in Humana by 161.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider’s stock valued at $446,911,000 after acquiring an additional 1,060,767 shares during the last quarter. National Pension Service boosted its stake in Humana by 2.8% during the 3rd quarter. National Pension Service now owns 189,601 shares of the insurance provider’s stock valued at $49,328,000 after acquiring an additional 5,150 shares during the last quarter. Long Focus Capital Management LLC bought a new position in Humana during the 3rd quarter valued at $34,212,000. Finally, Tejara Capital Ltd bought a new position in Humana during the 3rd quarter valued at $1,873,000. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Stock Performance

Shares of HUM stock opened at $309.85 on Wednesday. Humana has a one year low of $163.11 and a one year high of $315.35. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The company has a 50 day moving average price of $210.28 and a 200 day moving average price of $226.76. The firm has a market capitalization of $37.20 billion, a price-to-earnings ratio of 33.14, a price-to-earnings-growth ratio of 2.84 and a beta of 0.68.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. During the same quarter in the prior year, the business earned $11.58 earnings per share. The business’s quarterly revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts anticipate that Humana will post 9 EPS for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s dividend payout ratio (DPR) is presently 37.86%.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.